Senate investigations panel to probe Mylan's EpiPen pricing

WASHINGTON (Reuters) - The U.S. Senate's permanent subcommittee on investigations has decided to look into Mylan Pharmaceuticals' pricing of the EpiPen, according to a press release issued on Wednesday.